Location History:
- Wilmington, DE (US) (1985 - 1993)
- Wallingford, PA (US) (1989 - 2000)
Company Filing History:
Years Active: 1985-2000
Title: **Peter R Bernstein: Innovator in Pharmaceutical Chemistry**
Introduction
Peter R Bernstein is a noted inventor based in Wallingford, PA, known for his significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 27 patents, Bernstein has been at the forefront of developing innovative compounds that address various medical conditions, particularly those associated with respiratory issues and enzymatic disorders.
Latest Patents
Among Bernstein's latest innovations are two noteworthy patents. The first involves *therapeutic neurokinin receptor antagonist compounds*, described as nonpeptide antagonists of Substance P and Neurokinin A, which are geared towards treating asthma and related conditions. These compounds of formula I, along with their N-oxides and pharmaceutically acceptable salts, offer new avenues for therapeutic interventions. The patent also includes pharmaceutical compositions and processes for preparing these compounds.
The second patent pertains to *proline derivatives*, specifically a novel 1-substituted-N-[2-methyl-1-(trifluoroacetyl)propyl]pyrrolidine-2-carboxamide. This compound acts as an inhibitor of human leukocyte elastase (HLE), making it useful for both research applications and potential treatments for diseases involving HLE. Similar to the first, this patent includes pharmaceutical compositions, preparation processes, and useful intermediates for synthesis.
Career Highlights
Throughout his career, Peter R Bernstein has worked with prestigious organizations such as Zeneca Limited and ICI Americas, Inc., contributing his expertise to important research and development projects within the pharmaceutical industry. His work has focused on synthesizing compounds that exhibit therapeutic benefits, marking him as a pivotal figure in the field.
Collaborations
Bernstein has collaborated with distinguished colleagues, including Frederick J Brown and Ying K Yee. These partnerships have played a crucial role in enhancing the scope and impact of his inventions, leading to advancements in drug development and therapeutic applications.
Conclusion
Peter R Bernstein's inventive efforts in pharmaceutical chemistry have resulted in numerous patents that hold promise for addressing critical health challenges. His dedication to research and collaboration underscores the importance of innovation in medicine. As he continues to advance his work, the relevance of his contributions to both science and patient care remains unwavering.